-
Mashup Score: 4Urology-Oncology Collaboration: Keys to Optimal Care in Metastatic Prostate Cancer - Damian Sorce & Manojkumar Bupathi - 7 hour(s) ago
Alicia Morgans hosts a discussion with Damian Sorce, a urologist, and Manoj Bupathi, a medical oncologist, on their collaboration in treating patients with metastatic hormone-sensitive prostate cancer. Dr. Sorce shares a case of a newly diagnosed patient with advanced disease, emphasizing the importance of immediate communication and coordination between urology and medical oncology for starting…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0AUA, ASTRO, SUO Release New Salvage Therapy Guidelines for Prostate Cancer | GU Oncology Now - 2 day(s) ago
Part 1 covered treatment decision-making during suspected BCR following radical prostatectomy.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 5Exploring the Multifaceted Role of a Medical Oncologist in Advanced Prostate Cancer Care and Management - Alicia Morgans - 3 day(s) ago
Alicia Morgans discusses her diverse roles at Dana-Farber, where she primarily treats prostate cancer patients, guiding them through various stages of their disease. Beyond patient care, Dr. Morgans is actively involved in teaching, research, and as the Medical Director of the Survivorship Program, she extends her expertise to a wide range of cancer patients. Reflecting on her career, Dr….
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 5Advancing Health Equity: The American Cancer Society's Strategic Approach - Tawana Thomas-Johnson - 3 day(s) ago
Tawana Thomas-Johnson discusses her role as the Senior Vice President and Chief Diversity Officer at the American Cancer Society (ACS). She manages both internal and external Diversity, Equity, and Inclusion (DEI) initiatives, focusing on workforce diversity and health equity. Ms. Thomas-Johnson’s career path, influenced by her background in political science and divinity, reflects her…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Advancing health equity: @AmericanCancer's strategic approach. Join @TawanaTJohnson and @AndreaMiyahira to learn about the importance of continuous learning, community engagement, and the ACS's initiatives tackling #ProstateCancer disparities > https://t.co/TiaSmdVkPD @PCFnews https://t.co/dyeDIipd3d
-
-
Mashup Score: 2An Overview of Strategies and Therapeutic Advances in Metastatic Prostate Cancer - Rana McKay - 3 day(s) ago
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Rana McKay, MD, Medical Oncologist, Associate Professor of Medicine, UC San Diego School of Medicine, San Diego, CA Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center,…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 12The De-Escalate Trial: Intermittently Stopping Prostate Cancer Treatments to Improve Quality of Life - Guillaume Grisay - 3 day(s) ago
Guillaume Grisay introduces the De-Escalate trial, a study focused on intermittent treatment for metastatic hormone-naive prostate cancer patients who have achieved a deep PSA response after induction therapy. This innovative approach aims to preserve overall survival while improving patients’ quality of life by pausing ADT and AR pathway inhibitors, addressing the challenges of chronic…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3AZGP1 deficiency promotes angiogenesis in prostate cancer - Journal of Translational Medicine - 4 day(s) ago
Background Loss of AZGP1 expression is a biomarker associated with progression to castration resistance, development of metastasis, and poor disease-specific survival in prostate cancer. However, high expression of AZGP1 cells in prostate cancer has been reported to increase proliferation and invasion. The exact role of AZGP1 in prostate cancer progression remains elusive. Method AZGP1 knockout and overexpressing prostate cancer cells were generated using a lentiviral system. The effects of AZGP1 under- or over-expression in prostate cancer cells were evaluated by in vitro cell proliferation, migration, and invasion assays. Heterozygous AZGP1± mice were obtained from European Mouse Mutant Archive (EMMA), and prostate tissues from homozygous knockout male mice were collected at 2, 6 and 10 months for histological analysis. In vivo xenografts generated from AZGP1 under- or over-expressing prostate cancer cells were used to determine the role of AZGP1 in prostate cancer tumor growth, and
Categories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 7New Prostate Cancer Risk Variants Identified in Expanded Multi-Ancestry GWAS Meta-Analysis - Anqi Wang - 4 day(s) ago
Anqi Wang unveils findings from her study published in Nature Genetics. Dr. Wang’s research marks a significant advance in understanding the genetic landscape of prostate cancer, identifying a total of 451 independent risk loci, including 187 novel variants, through an expanded multi-ancestry meta-analysis. This study not only enlarges the scope of known genetic risk factors but also emphasizes…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 44
Prostate Cancer UK has today announced details of a £42 million screening trial, which aims to find the best way to screen men for prostate cancer and double the number of lives saved.
Source: www.icr.ac.ukCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Multidisciplinary Approach in the Treatment of Metastatic Prostate Cancer - Robert Dreicer - 6 day(s) ago
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Robert Dreicer, MD, MS, MACP, FASCO, Head, Medical Oncology Section, Deputy Director University of Virginia Comprehensive Cancer Center, Associate Director for Clinical Research, Co-Director Paul Mellon Urologic Oncology…
Source: www.urotoday.comCategories: General Medicine News, UrologyTweet-
Multidisciplinary approach in the treatment of metastatic #ProstateCancer. @CaPsurvivorship @DanaFarber moderates a discussion and presentation with Robert Dreicer @MedicineUVA in this independent medical education initiative supported by @LoxoLillyOnc > https://t.co/KuAdbDdaHk https://t.co/EfcqRGEkiX
-
Urology-oncology collaboration: Keys to optimal care in metastatic #ProstateCancer. Damian Sorce @ColoradoUro & Manojkumar Bupathi joins @CaPsurvivorship @DanaFarber in this discussion on UroToday > https://t.co/cEc3AUmE8t @BayerPharma https://t.co/Q6lfxCxTZu